Abemaciclib (Compound)

Synonyms:Abemaciclib, 1231929-97-7, LY2835219, Verzenio, LY2835219 free base, LY-2835219, N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine, UNII-60UAB198HK, N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine, Abemaciclib (ly2835219), 60UAB198HK, LY 2835219, HY-16297A, LY2835219 free base (Abemaciclib), CS-1230, 2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl), N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-1,3-benzodiazol-5-yl)pyrimidin-2-amine, N-{5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]pyrimidin-2-amine, LY2835219 (free base), Abemaciclib [USAN:INN], Verzenios, rimidin-2-amine, C27H32F2N8, Verzenio (TN), 6ZV, N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]py rimidin-2-amine, CDK4/6 dual inhibitor, LY2835210, ABEMACICLIB [MI], ABEMACICLIB [INN], ABEMACICLIB [JAN], Abemaciclib (JAN/USAN), ABEMACICLIB [USAN], ABEMACICLIB [WHO-DD], GTPL7382, SCHEMBL2487229, CHEMBL3301610, ABEMACICLIB [ORANGE BOOK], DTXSID20673119, EX-A521, LY 2835219 (free base), HMS3673I05, BCP13079, EX-A1588, BDBM50110183, MFCD22665744, NSC768073, NSC783671, s5716, 1231929-97-7, Verzenio,, AKOS025404907, CCG-269750, DB12001, NSC-768073, NSC-783671, SB16476, NCGC00351599-02, NCGC00351599-06, 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine, 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl)amine, AC-30666, AS-10230, DA-33422, LY2835219 Ms salt, Abemaciclib Ms salt, FT-0700134, LY 2835210, A12989, D10688, EN300-7406007, J-690083, Q23901483, [5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine, 2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-, 2-Pyrimidinamine,N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-, N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl]pyrimidin-2-amine
Pubchem:PUBCHEM:46220502
Id:86d7c3c8-e15e-534c-9e40-8fc54422fb63
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Abemaciclib's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Abemaciclib.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Abemaciclib.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.